nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Anileridine—Cetirizine—allergic rhinitis	0.938	1	CrCrCtD
Alvimopan—Urinary retention—Cyproheptadine—allergic rhinitis	0.00328	0.061	CcSEcCtD
Alvimopan—Urinary retention—Dimenhydrinate—allergic rhinitis	0.00266	0.0496	CcSEcCtD
Alvimopan—Urinary retention—Diphenhydramine—allergic rhinitis	0.00266	0.0496	CcSEcCtD
Alvimopan—Connective tissue disorder—Desloratadine—allergic rhinitis	0.00228	0.0424	CcSEcCtD
Alvimopan—Urinary retention—Cetirizine—allergic rhinitis	0.00193	0.0359	CcSEcCtD
Alvimopan—Back pain—Olopatadine—allergic rhinitis	0.00167	0.031	CcSEcCtD
Alvimopan—Dyspepsia—Cyproheptadine—allergic rhinitis	0.00149	0.0277	CcSEcCtD
Alvimopan—Dyspepsia—Desloratadine—allergic rhinitis	0.00145	0.027	CcSEcCtD
Alvimopan—Constipation—Cyproheptadine—allergic rhinitis	0.00145	0.027	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Desloratadine—allergic rhinitis	0.00142	0.0265	CcSEcCtD
Alvimopan—Urinary tract disorder—Cetirizine—allergic rhinitis	0.00139	0.0258	CcSEcCtD
Alvimopan—Urethral disorder—Cetirizine—allergic rhinitis	0.00138	0.0256	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Olopatadine—allergic rhinitis	0.00121	0.0226	CcSEcCtD
Alvimopan—Dyspepsia—Diphenhydramine—allergic rhinitis	0.00121	0.0226	CcSEcCtD
Alvimopan—Dyspepsia—Dimenhydrinate—allergic rhinitis	0.00121	0.0226	CcSEcCtD
Alvimopan—Flatulence—Cetirizine—allergic rhinitis	0.00121	0.0224	CcSEcCtD
Alvimopan—Malnutrition—Flunisolide—allergic rhinitis	0.0012	0.0224	CcSEcCtD
Alvimopan—Back pain—Cetirizine—allergic rhinitis	0.00118	0.022	CcSEcCtD
Alvimopan—Constipation—Dimenhydrinate—allergic rhinitis	0.00118	0.0219	CcSEcCtD
Alvimopan—Constipation—Diphenhydramine—allergic rhinitis	0.00118	0.0219	CcSEcCtD
Alvimopan—Urinary tract disorder—Montelukast—allergic rhinitis	0.00116	0.0217	CcSEcCtD
Alvimopan—Back pain—Flunisolide—allergic rhinitis	0.00116	0.0216	CcSEcCtD
Alvimopan—Connective tissue disorder—Montelukast—allergic rhinitis	0.00116	0.0215	CcSEcCtD
Alvimopan—Urethral disorder—Montelukast—allergic rhinitis	0.00115	0.0215	CcSEcCtD
Alvimopan—Dyspepsia—Loratadine—allergic rhinitis	0.000934	0.0174	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Loratadine—allergic rhinitis	0.000916	0.017	CcSEcCtD
Alvimopan—Constipation—Loratadine—allergic rhinitis	0.000907	0.0169	CcSEcCtD
Alvimopan—Dyspepsia—Cetirizine—allergic rhinitis	0.000879	0.0164	CcSEcCtD
Alvimopan—Dyspepsia—Flunisolide—allergic rhinitis	0.000864	0.0161	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000862	0.016	CcSEcCtD
Alvimopan—Constipation—Cetirizine—allergic rhinitis	0.000853	0.0159	CcSEcCtD
Alvimopan—Constipation—Flunisolide—allergic rhinitis	0.000839	0.0156	CcSEcCtD
Alvimopan—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.000837	0.0156	CcSEcCtD
Alvimopan—Dyspepsia—Montelukast—allergic rhinitis	0.000737	0.0137	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000723	0.0134	CcSEcCtD
Alvimopan—Hypokalaemia—Betamethasone—allergic rhinitis	0.000715	0.0133	CcSEcCtD
Alvimopan—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000715	0.0133	CcSEcCtD
Alvimopan—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000625	0.0116	CcSEcCtD
Alvimopan—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000587	0.0109	CcSEcCtD
Alvimopan—Malnutrition—Hydrocortisone—allergic rhinitis	0.000554	0.0103	CcSEcCtD
Alvimopan—Malnutrition—Methylprednisolone—allergic rhinitis	0.00052	0.00968	CcSEcCtD
Alvimopan—Back pain—Triamcinolone—allergic rhinitis	0.000504	0.00939	CcSEcCtD
Alvimopan—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000398	0.0074	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.00039	0.00726	CcSEcCtD
Alvimopan—Dyspepsia—Triamcinolone—allergic rhinitis	0.000375	0.00697	CcSEcCtD
Alvimopan—Dyspepsia—Methylprednisolone—allergic rhinitis	0.000374	0.00696	CcSEcCtD
Alvimopan—OPRM1—IL4-mediated signaling events—CCL11—allergic rhinitis	0.000355	0.0453	CbGpPWpGaD
Alvimopan—Dyspepsia—Dexamethasone—allergic rhinitis	0.00034	0.00633	CcSEcCtD
Alvimopan—Dyspepsia—Betamethasone—allergic rhinitis	0.00034	0.00633	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000333	0.0062	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000333	0.0062	CcSEcCtD
Alvimopan—OPRM1—IL4-mediated signaling events—IL5—allergic rhinitis	0.00024	0.0306	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.000218	0.0278	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.000202	0.0258	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000196	0.025	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—IL17A—allergic rhinitis	0.000192	0.0244	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.000191	0.0244	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.000177	0.0226	CbGpPWpGaD
Alvimopan—OPRM1—IL4-mediated signaling events—IL10—allergic rhinitis	0.000175	0.0224	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000173	0.0221	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000172	0.0219	CbGpPWpGaD
Alvimopan—OPRM1—IL4-mediated signaling events—IL4—allergic rhinitis	0.000171	0.0218	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—PTGDR2—allergic rhinitis	0.000161	0.0206	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000159	0.0202	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000152	0.0194	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	0.00015	0.0191	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CCL11—allergic rhinitis	0.000145	0.0185	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.000142	0.0181	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000139	0.0177	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000136	0.0173	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000132	0.0168	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000131	0.0167	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	0.000128	0.0164	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.000125	0.0159	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000119	0.0152	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	0.000118	0.015	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—PTGDR2—allergic rhinitis	0.000116	0.0148	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	0.000115	0.0147	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—TAC1—allergic rhinitis	0.000105	0.0134	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CYSLTR1—allergic rhinitis	0.000103	0.0132	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	0.000101	0.0129	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCL11—allergic rhinitis	0.0001	0.0128	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—PTGDR2—allergic rhinitis	9.77e-05	0.0125	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	9.73e-05	0.0124	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	9.54e-05	0.0122	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CYSLTR1—allergic rhinitis	9.08e-05	0.0116	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCL11—allergic rhinitis	8.77e-05	0.0112	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	8.36e-05	0.0107	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CYSLTR1—allergic rhinitis	7.67e-05	0.00979	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PTGDR2—allergic rhinitis	7.45e-05	0.00951	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL11—allergic rhinitis	7.41e-05	0.00945	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—CD4—allergic rhinitis	7.4e-05	0.00944	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—TAC1—allergic rhinitis	7.26e-05	0.00927	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	7.07e-05	0.00902	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PTGDR2—allergic rhinitis	6.77e-05	0.00864	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.54e-05	0.00834	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—NFKB1—allergic rhinitis	6.37e-05	0.00813	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—TAC1—allergic rhinitis	6.37e-05	0.00813	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PTGDR2—allergic rhinitis	5.94e-05	0.00757	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.85e-05	0.00746	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PTGDR2—allergic rhinitis	5.52e-05	0.00705	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—TAC1—allergic rhinitis	5.38e-05	0.00687	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.31e-05	0.00678	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—TGFB1—allergic rhinitis	5.31e-05	0.00677	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL11—allergic rhinitis	5.13e-05	0.00655	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	5.13e-05	0.00654	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PTGDR2—allergic rhinitis	5.02e-05	0.0064	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.66e-05	0.00594	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL11—allergic rhinitis	4.5e-05	0.00574	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.33e-05	0.00553	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—TAC1—allergic rhinitis	4.1e-05	0.00524	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PTGDR2—allergic rhinitis	4e-05	0.0051	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.94e-05	0.00502	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL5—allergic rhinitis	3.82e-05	0.00487	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL11—allergic rhinitis	3.8e-05	0.00485	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—TAC1—allergic rhinitis	3.73e-05	0.00476	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—TAC1—allergic rhinitis	3.6e-05	0.00459	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTGDR2—allergic rhinitis	3.51e-05	0.00447	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL5—allergic rhinitis	3.47e-05	0.00442	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL5—allergic rhinitis	3.35e-05	0.00427	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—TAC1—allergic rhinitis	3.27e-05	0.00417	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CYSLTR1—allergic rhinitis	3.14e-05	0.004	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—TAC1—allergic rhinitis	3.04e-05	0.00388	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL5—allergic rhinitis	3.04e-05	0.00388	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL11—allergic rhinitis	3.03e-05	0.00387	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTGDR2—allergic rhinitis	2.96e-05	0.00378	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL5—allergic rhinitis	2.83e-05	0.00361	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—TAC1—allergic rhinitis	2.76e-05	0.00352	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CYSLTR1—allergic rhinitis	2.75e-05	0.00351	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL11—allergic rhinitis	2.66e-05	0.00339	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL5—allergic rhinitis	2.57e-05	0.00328	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CYSLTR1—allergic rhinitis	2.33e-05	0.00297	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL11—allergic rhinitis	2.25e-05	0.00287	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TAC1—allergic rhinitis	2.2e-05	0.00281	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL5—allergic rhinitis	2.05e-05	0.00261	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TAC1—allergic rhinitis	1.93e-05	0.00246	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL5—allergic rhinitis	1.79e-05	0.00229	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TAC1—allergic rhinitis	1.63e-05	0.00208	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL5—allergic rhinitis	1.52e-05	0.00194	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SMAD3—allergic rhinitis	1.44e-05	0.00184	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SMAD3—allergic rhinitis	1.26e-05	0.00161	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SMAD3—allergic rhinitis	1.07e-05	0.00136	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NFKB1—allergic rhinitis	7.32e-06	0.000934	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NFKB1—allergic rhinitis	6.42e-06	0.000819	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TGFB1—allergic rhinitis	6.1e-06	0.000778	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NFKB1—allergic rhinitis	5.43e-06	0.000692	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFB1—allergic rhinitis	5.35e-06	0.000683	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFB1—allergic rhinitis	4.52e-06	0.000577	CbGpPWpGaD
